The ADITEC project has a special Ethical Review Board (ERB): an independent consultant body of the ethical issues of the project. This Board, which will…
After a rigorous selection process, the MOMP antigen from Chlamydia has been selected as the 3rd model antigen. A list of 36 possible antigens for…
Chlamydia MOMP selected as 3rd Model Antigen So far, within the ADITEC project, the research partners worked with two different antigens in their studies: H56…
SSI is a public enterprise under the Danish Ministry of Health. For more than 100 years SSI’s main task has been to secure the preparedness…
Aditec partner Novartis Vaccines Institute for Global Health (NVGH) organizes, together with University of Siena and Novartis Vaccines Academy, the 3rd Master in Vaccinology and…
The Bill & Melinda Gates Foundation’s TB Vaccine Accelerator Program is requesting applications for projects that will help meet one or both of the following…
Are you a student or post-doc and interested in vaccinology? Vaccines Today has started a contest for fun and creative communication concepts to promote vaccination.…
Deadline for submission is: Wednesday 15th August 2012, 23:59 hours CEST Research groups are invited to submit full proposals to improve the selection, production/formulation and…
Welcome to our first newsletter! Dear partner, I’m happy to send you the first electronic newsletter of ADITEC, the EU/FP7 funded project about Advanced Immunization…
ADITEC partner TBVI has opened a call for proposals for early clinical development of new, promising TB vaccines. This call focuses on support for cGMP…